Literature DB >> 4773549

Capillary fragility and doxium. A controlled clinical trial.

R Rasch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4773549     DOI: 10.1007/bf00461693

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Caclium dobesilate in diabetic retinopathy.

Authors:  R Sévin; J F Cuendet
Journal:  Ophthalmologica       Date:  1969       Impact factor: 3.250

2.  [Treatment of diabetic retinopathy and recurrent hemorrhages into the vitreous with calcium dobesilate].

Authors:  M Favre
Journal:  Ophthalmologica       Date:  1970       Impact factor: 3.250

3.  The action of calcium dobesilate on capillary permeability in diabetics.

Authors:  R Sévin; J F Cuendet
Journal:  Ophthalmologica       Date:  1971       Impact factor: 3.250

4.  Cutaneous capillary resistance and retinal haemorrhage in diabetes.

Authors:  P R Hunter; A Bloom; J H Kelsey; R Porter
Journal:  Diabetologia       Date:  1971-02       Impact factor: 10.122

5.  Quantitative measurements of skin capillary resistance in hypophysectomized long-term diabetics.

Authors:  N J Christensen; A B Terkildsen
Journal:  Diabetes       Date:  1971-05       Impact factor: 9.461

6.  [Capillary resistance and diabetic retinopathy. Effect of Etamsylate (cyclonamine or Dicynone)].

Authors:  R Sévin; J F Cuendet
Journal:  Ophthalmologica       Date:  1968       Impact factor: 3.250

  6 in total
  2 in total

1.  The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.

Authors:  H W Larsen; E Sander; R Hoppe
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

2.  Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Farzad Hami Adl; Dima Andalib; Hassan Khojasteh-Jafari; Kamyar Ghabili
Journal:  Mol Vis       Date:  2013-01-10       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.